WINDTREE THERAPEUTICS INC Contracts & Agreements
247 Contracts & Agreements
- Business Finance (134 contracts)
- Business Operations (21)
- Human Resources (50)
- Intellectual Property (5)
- Mergers & Acquisitions (1)
- Real Estate (8)
- Uncategorized (28)
- Exchange and Termination Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024 (Filed With SEC on January 25, 2024)
- Registration Rights Agreement, by and between the Company and affiliates of Deerfield Management Company, L.P., effective upon January 24, 2024 (Filed With SEC on January 25, 2024)
- At The Market Offering Agreement, dated as of November 9, 2023, by and between Windtree Therapeutics, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 9, 2023)
- Amended and Restated Windtree Therapeutics, Inc. 2020 Equity Incentive Plan (Filed With SEC on August 16, 2023)
- Underwriting Agreement, dated April 20, 2023, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 24, 2023)
- Warrant Agency Agreement (including form of global Common Warrant), dated April 24, 2023, by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on April 24, 2023)
- Form of Underwriting Agreement (Filed With SEC on April 7, 2023)
- Form of Common Warrant (Filed With SEC on April 7, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on April 7, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on April 7, 2023)
- Third Amendment to Lease Agreement dated November 24, 2014 between TR Stone Manor Corp. and Windtree (Filed With SEC on March 31, 2023)
- Form of New Warrant (Filed With SEC on February 22, 2023)
- Form of Inducement Letter (Filed With SEC on February 22, 2023)
- Form of New Warrant (Filed With SEC on January 26, 2023)
- Form of Inducement Letter (Filed With SEC on January 26, 2023)
- Amended and Restated License, Development and Commercialization Agreement, by and among Lees Pharmaceutical (HK) Ltd., Zhaoke Pharmaceutical (Hefei) Co. Ltd., and Windtree... (Filed With SEC on November 14, 2022)
- Employment Agreement by and between Windtree and Diane Carman, dated as of July 1, 2021 (Filed With SEC on March 31, 2022)
- Agreement for Scientific Collaboration between Universita degli Studi di Milano-Bicocca and CVie Therapeutics Ltd, a wholly-owned subsidiary of the Registrant, dated March 19, 2021 (Filed With SEC on May 13, 2021)
- Description of Securities (Filed With SEC on March 29, 2021)
- Underwriting Agreement, dated March 23, 2021, by and among the Company and Oppenheimer & Co. Inc., as representative for the several underwriters named therein (Filed With SEC on March 24, 2021)
- Form of Warrant (Filed With SEC on March 24, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on March 24, 2021)
- 2020 Equity Incentive Plan (Filed With SEC on December 31, 2020)
- Collaboration Agreement dated as of October 10, 2014, by and between Battelle Memorial Institute and Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) (Filed With SEC on November 16, 2020)
- Amended and Restated Supply Agreement, dated as of December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and Laboratorios Del Dr.... (Filed With SEC on November 16, 2020)
- Amended and Restated Sublicense and Collaboration Agreement, dated December 3, 2004, by and between Discovery Laboratories, Inc. (predecessor-in-interest to Windtree) and... (Filed With SEC on November 16, 2020)
- Project Financing Agreement, dated August 12, 2020, by and between Windtree and Lees Pharmaceutical (HK) Ltd (Filed With SEC on November 16, 2020)
- Separation Agreement by and between Windtree and John A. Tattory, dated as of July 29, 2020 (Filed With SEC on August 14, 2020)
- Employment Agreement by and between the Company and John Hamill dated as of July 20, 2020 (Filed With SEC on July 23, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to the Registration Statement on Form S-1, filed on January 27, 2020, as amended (Filed With SEC on May 22, 2020)
- Form of Warrant Agency Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 22, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 19, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 19, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 14, 2020)
- Form of Series I Amendment dated May 6, 2020 (Filed With SEC on May 7, 2020)
- Form of Underwriting Agreement (Filed With SEC on May 6, 2020)
- Form of Warrant to be issued to purchasers of units and the underwriters pursuant to this Registration Statement on Form S-1 (Filed With SEC on May 6, 2020)
- Form of Warrant Agreement between Windtree Therapeutics, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on May 6, 2020)
- Form of Series I Warrant Amendment dated May 6, 2020 to the Series I Warrant dated December 6, 2019 (Filed With SEC on May 6, 2020)
- Amendment No. 1 to Payment Restructuring Agreement effective December 7, 2018, between Windtree and Battelle Memorial Institute (Filed With SEC on May 6, 2020)
- Binding Term Sheet dated March 18, 2020, between Windtree and Lees Pharmaceutical (HK) LTD (Filed With SEC on May 6, 2020)
- Loan Agreement dated March 17, 2020, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on May 6, 2020)
- Form of Series F Warrant Amendment dated April 24, 2020 (Filed With SEC on April 29, 2020)
- Note dated April 20, 2020, between Windtree Therapeutics, Inc. and Newtek Small Business Finance, LLC (Filed With SEC on April 24, 2020)
- Description of Securities (Filed With SEC on April 3, 2020)
- Form of Non-Employee Director Option Agreement under Windtrees 2011 Long-Term Incentive Plan (Filed With SEC on April 3, 2020)
- Employment Agreement dated March 1, 2020, between Windtree and Eric Curtis (Filed With SEC on April 3, 2020)
- Amendment to No. 1 dated February 20, 2020 to the Securities Purchase Agreement dated December 6, 2019 by and among Windtree and the purchasers party thereto (Filed With SEC on April 3, 2020)
- Form of Series I Warrant (Filed With SEC on December 9, 2019)
- Form of Securities Purchase Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
- Form of Registration Rights Agreement, dated December 6, 2019 by and among the Company and the purchasers party thereto (Filed With SEC on December 9, 2019)
- Loan Agreement (Filed With SEC on October 28, 2019)
- Form of Series E Warrant dated December 11, 2018 (Filed With SEC on April 16, 2019)
- Form of Indemnification Agreement between Windtree and certain named directors (Filed With SEC on April 16, 2019)
- Loan Agreement dated October 25, 2018, between CVie Therapeutics, Lees Pharmaceutical Holdings Limited, and O-Bank Co., Ltd (Filed With SEC on April 16, 2019)
- Shareholder Loan Agreement dated April 24, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
- Shareholder Loan Agreement dated September 20, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
- Shareholder Loan Agreement dated October 26, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
- Shareholder Loan Agreement dated November 16, 2018, between Lees Pharmaceutical International Limited and CVie Therapeutics (Filed With SEC on April 16, 2019)
- WINDTREE THERAPEUTICS, INC. 2011 LONG-TERM INCENTIVE PLAN (AS AMENDED) (Filed With SEC on December 31, 2018)
- Form of AEROSURF Warrant (Filed With SEC on December 21, 2018)
- Form of Series F Warrant (Filed With SEC on December 21, 2018)
- Form of Series G Warrant (Filed With SEC on December 21, 2018)
- Merger Agreement, dated December 21, 2018, by and among the Company, WT Acquisition Corp., an exempted company with limited liability incorporated under the laws of the Cayman... (Filed With SEC on December 21, 2018)
- Indemnification Letter Agreement, dated December 21, 2018 by and between the Company and Lees Pharmaceutical Holdings Limited (Filed With SEC on December 21, 2018)
- Securities Purchase Agreement, dated December 21, 2018 by and among the Company and the purchasers named on Schedule I thereto (Filed With SEC on December 21, 2018)
- Registration Rights Agreement, dated December 21, 2018 by and among the Company and the purchasers named on Schedule I thereto (Filed With SEC on December 21, 2018)
- Amendment No. 4 to Restricted Stock Unit Award Agreement of Craig Fraser dated as of December 13, 2018 (Filed With SEC on December 14, 2018)
- Amendment No. 4 to Restricted Stock Unit Award Agreement of John Tattory dated as of December 13, 2018 (Filed With SEC on December 14, 2018)
- Amendment No. 4 to Restricted Stock Unit Award Agreement of Steven G. Simonson, M.D. dated as of December 13, 2018 (Filed With SEC on December 14, 2018)
- Loan Agreement (Filed With SEC on December 7, 2018)
- Payment Restructuring Agreement between the Company and Battelle Memorial Institute effective as of December 7, 2018 (Filed With SEC on December 7, 2018)
- Loan Agreement between the Company and LPH Investments Ltd. effective as of November 19, 2018 (Filed With SEC on November 23, 2018)
- Loan Agreement (Filed With SEC on November 8, 2018)
- Loan Agreement (Filed With SEC on October 25, 2018)
- Amendment to Irrevocable Standby Letter of Credit (Filed With SEC on October 16, 2018)
- Loan Agreement (Filed With SEC on October 3, 2018)
- AMENDMENT NO. 3 TO Restricted Stock Unit Award Agreement (Filed With SEC on October 3, 2018)
- AMENDMENT NO. 3 TO Restricted Stock Unit Award Agreement (Filed With SEC on October 3, 2018)
- AMENDMENT NO. 3 TO Restricted Stock Unit Award Agreement (Filed With SEC on October 3, 2018)
- Loan Agreement (Filed With SEC on September 14, 2018)
- Loan Agreement (Filed With SEC on August 29, 2018)
- Loan Agreement (Filed With SEC on August 20, 2018)
- AMENDMENT NO. 2 TO Restricted Stock Unit Award Agreement (Filed With SEC on July 24, 2018)
- AMENDMENT NO. 2 TO Restricted Stock Unit Award Agreement (Filed With SEC on July 24, 2018)
- AMENDMENT NO. 2 TO Restricted Stock Unit Award Agreement (Filed With SEC on July 24, 2018)
- WINDTREE THERAPEUTICS, INC. Series D WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on July 6, 2018)
- SECURED Convertible Promissory Note (Filed With SEC on July 6, 2018)
- Guaranty and Replenishment Agreement (Filed With SEC on June 19, 2018)
- Windtrees 2011 Long-Term Incentive Plan, as amended (Filed With SEC on April 17, 2018)
- Form of Restricted Stock Unit Award Agreement for Employees under Windtrees 2011 Long-Term Incentive Plan (Filed With SEC on April 17, 2018)
- Form of Series C Warrant (Filed With SEC on April 4, 2018)
- Securities Purchase Agreement dated March 30, 2018 (Filed With SEC on April 4, 2018)
- Registration Rights Agreement dated March 30, 2018 (Filed With SEC on April 4, 2018)
- Amendment No. 1 to Employment Agreement of Craig Fraser dated as of March 13, 2018 (Filed With SEC on March 16, 2018)
- Amendment No. 2 to Employment Agreement of John Tattory dated as of March 13, 2018 (Filed With SEC on March 16, 2018)
- Amendment No. 2 to Employment Agreement of Steven G. Simonson, M.D., dated as of March 13, 2018 (Filed With SEC on March 16, 2018)
- Loan Agreement between the Company and LPH Investments Ltd. dated as of March 1, 2018 (Filed With SEC on March 5, 2018)
- Security Agreement between the Company and LPH Investments Ltd. dated as of March 1, 2018 (Filed With SEC on March 5, 2018)
- FIFTH AMENDMENT TO LEASE AGREEMENT (Filed With SEC on March 1, 2018)
- Loan Agreement between the Company and LPH Investments Ltd (Filed With SEC on January 12, 2018)
- Amendment No. 1 dated as of August 14, 2017 to the License Development and Commercialization Agreement by and between the Company and Lees Pharmaceutical (HK) Ltd. dated as of... (Filed With SEC on November 14, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 1, 2017)
- EXCHANGE AND TERMINATION AGREEMENT (Filed With SEC on November 1, 2017)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT by and between windtree therapeutics, inc. and Lee’s pharmaceutical (hk) LTD. Table of Contents (Filed With SEC on August 21, 2017)
- Loan Agreement (Filed With SEC on August 18, 2017)
- WINDTREE THERAPEUTICS, INC. SERIES A-1 WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on February 15, 2017)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 15, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 15, 2017)
- Fourth Amendment to Lease Agreement dated as of April 29, 2016, by and between New Landlord and the Company (Filed With SEC on May 31, 2016)
- Second Amendment to Collaboration Agreement between the Company and Battelle dated March 31, 2016 (Filed With SEC on April 5, 2016)
- Discoverys Amended and Restated 2011 Long-Term Incentive Plan effective as of January 22, 2016 (Filed With SEC on March 29, 2016)
- Amendment No. 1 dated February 11, 2016 to the At-the-Market Equity Sales Agreement dated February 11, 2013 by and between the Company and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on February 16, 2016)
- Employment Agreement by and between the Company and Craig Fraser dated as of February 1, 2016 (Filed With SEC on February 3, 2016)
- Option Award Agreement between the Company and Craig Fraser (Filed With SEC on February 3, 2016)
- Form of Indemnification Agreement between the Company and its named executive officers, including Craig Fraser, and directors (Filed With SEC on February 3, 2016)
- Amendment dated as of August 4, 2015 to Collaboration Agreement dated as of October 14, 2014 between Discovery and Battelle Memorial Institute (Filed With SEC on August 10, 2015)
- Second Amendment dated July 22, 2015 to Facility Agreement dated February 13, 2013 by and between the Company and Deerfield (Filed With SEC on July 24, 2015)
- Underwriting Agreement dated July 17, 2015, between Discovery Laboratories, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on July 17, 2015)
- Form of Series A Warrant (Filed With SEC on July 17, 2015)
- Form of Pre-Funded Series B Warrant (Filed With SEC on July 17, 2015)
- Form of Series B Warrant (Filed With SEC on July 17, 2015)
- Amendment dated July 9, 2015 to Facility Agreement dated February 13, 2013 by and between the Company and Deerfield (Filed With SEC on July 9, 2015)
- Employment Agreement dated as of December 19, 2014, by and between Discovery and Steven G. Simonson, M.D (Filed With SEC on May 11, 2015)
- Amendment dated December 29, 2014 to Employment Agreement dated as of December 19, 2014, effective as of April 1, 2015, by and between Discovery and Steven G. Simonson, M.D (Filed With SEC on May 11, 2015)
- Amendment effective May 7, 2015, to Research and Development Services Agreement dated as of June 22, 2012, by and between Discovery and Battelle Memorial Institute (Filed With SEC on May 11, 2015)
- Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under Discoverys 2011 Long-Term Incentive Plan (Filed With SEC on March 16, 2015)
- Amendment dated December 29, 2014 to Employment Agreement dated as of April 1, 2013, by and between Discovery and John G. Cooper (Filed With SEC on March 16, 2015)
- Amendment dated December 29, 2014 to Employment Agreement dated as of April 1, 2013, by and between Discovery and Thomas F. Miller, Ph.D., MBA (Filed With SEC on March 16, 2015)
- Amendment dated December 29, 2014 to Employment Agreement dated as of April 1, 2013, by and between Discovery and Mary B. Templeton (Filed With SEC on March 16, 2015)
- Amendment dated December 29, 2014 to Employment Agreement dated as of March 21, 2014, by and between Discovery and John A. Tattory (Filed With SEC on March 16, 2015)
- Warrant, dated as of October 10, 2014, issued to Battelle Memorial Institute (Battelle) under a Collaboration Agreement dated as of October 10, 2014 (Collaboration Agreement),... (Filed With SEC on November 7, 2014)
- Second Warrant, dated as of October 10, 2014, issued to Battelle under the Collaboration Agreement (Filed With SEC on November 7, 2014)
- Collaboration Agreement dated as of October 10, 2014, by and between Battelle and Discovery (Filed With SEC on November 7, 2014)
- Amendment to Discoverys 2011 Long-Term Incentive Compensation Plan effective June 10, 2014 (Filed With SEC on August 7, 2014)
- Employment Agreement dated as of March 21, 2014 between Discovery and John Tattory (Filed With SEC on May 12, 2014)
- Employment Agreement dated as of April 1, 2013, between Discovery Laboratories, Inc. and Russell G. Clayton (Filed With SEC on March 17, 2014)
- Employment Agreement dated as of April 1, 2013, between Discovery Laboratories, Inc. and Mary B. Templeton (Filed With SEC on March 17, 2014)
- Form of Warrant to Purchase Common Stock of Discovery Laboratories, Inc (Filed With SEC on December 6, 2013)
- Master Services Agreement dated October 24, 2013 between Discovery and DSM (Filed With SEC on November 12, 2013)
- Underwriting Agreement dated October 31, 2013 between Discovery Laboratories, Inc., Stifel, Nicolaus & Company, Incorporated and Piper Jaffray & Co. as representatives of the... (Filed With SEC on October 31, 2013)
- Extension, dated as of July 16, 2013, of Lease dated as of December 3, 2004, between Discovery, as successor-in-interest to Laureate Pharma, Inc. (Tenant), and Norwell Land... (Filed With SEC on August 8, 2013)
- Pharmaceutical Manufacturing and Supply Agreement dated August 7, 2013 between Discovery and DSM Pharmaceuticals, Inc (Filed With SEC on August 8, 2013)
- Form of Warrant to Purchase Common Stock of Discovery Laboratories, Inc (Filed With SEC on June 14, 2013)
- Underwriting Agreement dated May 10, 2013 between Discovery Laboratories, Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on May 10, 2013)
- Employment Agreement dated as of April 1, 2013, between Discovery Laboratories, Inc. and John G. Cooper (Filed With SEC on April 2, 2013)
- Employment Agreement dated as of April 1, 2013, between Discovery Laboratories, Inc. and Thomas F. Miller, Ph.D., MBA (Filed With SEC on April 2, 2013)
- Employment Agreement dated as of May 4, 2012 between Discovery and Russell G. Clayton (Filed With SEC on March 15, 2013)
- Employment Agreement dated as of May 4, 2012 between Discovery and Mary B. Templeton (Filed With SEC on March 15, 2013)
- Form of Warrant to Purchase Common Stock of Discovery Laboratories, Inc (Filed With SEC on March 15, 2013)
- Form of Promissory Note made by Discovery Laboratories, Inc. in favor of Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield Special... (Filed With SEC on March 15, 2013)
- Facility Agreement, dated February 13, 2013, between Discovery Laboratories, Inc. and Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P.,... (Filed With SEC on March 15, 2013)
- Registration Rights Agreement, dated February 13, 2013, between Discovery Laboratories, Inc. and Deerfield Private Design Fund II, L.P., Deerfield Private Design International II,... (Filed With SEC on March 15, 2013)
- Security Agreement, dated February 13, 2013, between Discovery Laboratories, Inc. and Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P.,... (Filed With SEC on March 15, 2013)
- At-the-Market Equity Offering Sales Agreement between Stifel, Nicolaus & Company, Incorporated and the Company, dated February 11, 2013 (Filed With SEC on February 13, 2013)
- Second Amendment to Lease Agreement dated as of January 3, 2013, by and between TR Stone Manor Corp. and Discovery Laboratories, Inc (Filed With SEC on January 8, 2013)
- Separation Agreement and Plenary Release dated as of December 23, 2012, between the Company and W. Thomas Amick (Filed With SEC on January 4, 2013)
- Indemnification Agreement dated as of January 3, 2013, between the Company and Joseph M. Mahady (Filed With SEC on January 4, 2013)
- RESEARCH AND DEVELOPMENT SERVICES AGREEMENT (Filed With SEC on August 14, 2012)
- Product Development and Supply Agreement between Discovery and Lacey Manufacturing Company, a Division of Precision Engineered Products, LLC (Filed With SEC on May 15, 2012)
- Form of Employee Option Agreement under Discoverys 2011 Long-Term Incentive Plan (Filed With SEC on May 15, 2012)
- Form on Non-Employee Director Agreement under Discoverys 2011 Long-Term Incentive Plan (Filed With SEC on May 15, 2012)
- Employment Agreement dated as of May 4, 2012 by and between Discovery Laboratories, Inc. and Thomas F. Miller (Filed With SEC on May 11, 2012)
- Employment Agreement dated as of May 4, 2012 by and between Discovery Laboratories, Inc. and W. Thomas Amick (Filed With SEC on May 10, 2012)
- Employment Agreement dated as of May 4, 2012 by and between Discovery Laboratories, Inc. and John G. Cooper (Filed With SEC on May 10, 2012)
- Employment Agreement dated as of May 4, 2012 by and between Discovery Laboratories, Inc. and Thomas F. Miller (Filed With SEC on May 10, 2012)
- Underwriting Agreement dated March 16, 2012 by and among Discovery Laboratories, Inc., Lazard Capital Markets LLC, Stifel, Nicolaus and Company, Incorporated, and ROTH Capital... (Filed With SEC on March 16, 2012)
- Sales Agency Agreement between Lazard Capital Markets LLC and the Company, dated December 14, 2011 (Filed With SEC on December 14, 2011)
- Amendment dated August 11, 2011 to the Employment Agreement dated October 12, 2010 between Discovery and W. Thomas Amick, Chairman of the Board and Chief Executive Officer (Filed With SEC on August 15, 2011)
- SEPARATION OF EMPLOYMENT AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 18, 2011)
- VOTING AGREEMENT (Filed With SEC on March 31, 2011)
- 10,000,000Units DISCOVERYLABORATORIES, INC. CommonStock (par value $0.001) UNDERWRITINGAGREEMENT (Filed With SEC on February 16, 2011)
- DISCOVERYLABORATORIES, INC. Formof Series I Warrant To Purchase Common Stock (Filed With SEC on February 16, 2011)
- DISCOVERYLABORATORIES, INC. Formof Series II Warrant To Purchase Common Stock (Filed With SEC on February 16, 2011)
- SUPPLYAGREEMENT (Filed With SEC on December 29, 2010)
- EXECUTIONCOPY EMPLOYMENTAGREEMENT (Filed With SEC on November 15, 2010)
- DISCOVERYLABORATORIES, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on October 13, 2010)
- SECURITIES PURCHASEAGREEMENT (Filed With SEC on October 13, 2010)
- RESTRICTEDSTOCK AWARD AGREEMENT (Filed With SEC on October 1, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on August 9, 2010)
- /s/W. Thomas Amick Name: W. Thomas Amick (Filed With SEC on August 9, 2010)
- 35,714,286Units DISCOVERYLABORATORIES, INC. CommonStock (par value $0.001) UNDERWRITINGAGREEMENT (Filed With SEC on June 17, 2010)
- DISCOVERYLABORATORIES, INC. Formof Series I Warrant To Purchase Common Stock (Filed With SEC on June 17, 2010)
- DISCOVERYLABORATORIES, INC. Formof Series II Warrant To Purchase Common Stock (Filed With SEC on June 17, 2010)
- FORMOF WARRANT (Filed With SEC on June 14, 2010)
- COMMONSTOCK PURCHASE AGREEMENT byand between KINGSBRIDGECAPITAL LIMITED and DISCOVERYLABORATORIES, INC. datedas of June 11, 2010 TABLEOF CONTENTS (Filed With SEC on June 14, 2010)
- RetentionLetter (Filed With SEC on May 10, 2010)
- THIRDAMENDED AND RESTATED PROMISSORYNOTE (Filed With SEC on April 28, 2010)
- SECURITIES PURCHASEAGREEMENT (Filed With SEC on April 28, 2010)
- DISCOVERYLABORATORIES, INC. FORMOF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on April 28, 2010)
- 27,500,000Units DISCOVERYLABORATORIES, INC. CommonStock (par value $0.001) UNDERWRITINGAGREEMENT (Filed With SEC on February 18, 2010)
- DISCOVERYLABORATORIES, INC. Formof Warrant To Purchase Common Stock (Filed With SEC on February 18, 2010)
- AGREEMENT (Filed With SEC on September 4, 2009)
- SEPARATION OF EMPLOYMENTAGREEMENT AND GENERAL RELEASE (Filed With SEC on September 4, 2009)
- Exhibit 10.1 14,000,000Shares of Common Stock andWarrants to Purchase up to 7,000,000 Shares of Common Stock DISCOVERYLABORATORIES, INC. CommonStock (par value $0.001) PLACEMENT... (Filed With SEC on May 8, 2009)
- Exhibit10.2 SUBSCRIPTIONAGREEMENT (Filed With SEC on May 8, 2009)
- Exhibit10.3 DISCOVERYLABORATORIES, INC. WarrantTo Purchase Common Stock (Filed With SEC on May 8, 2009)
- Executioncopy WARRANT (Filed With SEC on December 15, 2008)
- ExecutionCopy REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on December 15, 2008)
- FIRST AMENDMENT TO CREDIT AND SECURITY AGREEMENT (Filed With SEC on June 2, 2008)
- WARRANT (Filed With SEC on May 28, 2008)
- COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and DISCOVERY LABORATORIES, INC. dated as of May 22, 2008 (Filed With SEC on May 28, 2008)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 28, 2008)
- AMENDED AND RESTATED LICENSE AGREEMENT by and between DISCOVERY LABORATORIES, INC. (a Delaware corporation) and PHILIP MORRIS USA INC., d/b/a CHRYSALIS TECHNOLOGIES (a Virginia... (Filed With SEC on May 9, 2008)
- Exhibit 10.5 Confidential Treatment Requested Execution Version LICENSE AGREEMENT by and between DISCOVERY LABORATORIES, INC. (a Delaware corporation) and PHILIP MORRIS PRODUCTS... (Filed With SEC on May 9, 2008)
- MASTER SERVICES AGREEMENT (Filed With SEC on March 14, 2008)
- 10,000,000 Shares Discovery Laboratories, Inc. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on December 7, 2007)
- STOCK ISSUANCE AGREEMENT (Filed With SEC on November 5, 2007)
- DISCOVERY LABORATORIES, INC. 2007 LONG-TERM INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on August 9, 2007)
- Discovery Laboratories, Inc. 2007 Long Term Incentive Plan (Filed With SEC on June 28, 2007)
- EXECUTION COPY (Filed With SEC on May 24, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on April 27, 2007)
- LEASE AGREEMENT FOR OFFICE SPACE AT STONE MANOR CORPORATE CENTER EASTON ROAD DOYLESTOWN AND WARRINGTON TOWNSHIPS, PA (Filed With SEC on April 6, 2007)
- FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on April 6, 2007)
- Exhibit 10.1 14,050,000 Shares Discovery Laboratories, Inc. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on April 3, 2007)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2007)
- DISCOVERY LABORATORIES, INC. Warrant To Purchase Common Stock (Filed With SEC on November 22, 2006)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 22, 2006)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 22, 2006)
- SECOND AMENDED AND RESTATED PROMISSORY NOTE $8,500,000 October 25, 2006 (Filed With SEC on October 26, 2006)
- WARRANT AGREEMENT (Filed With SEC on October 26, 2006)
- SECOND AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on October 26, 2006)
- SECOND AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on October 26, 2006)
- AMENDMENT NO. 005 AND CONSENT (Filed With SEC on October 26, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2006)
- Exhibit 10.2 EXECUTION COPY EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 10, 2006)
- AMENDMENT NO. 004 (Filed With SEC on May 10, 2006)
- CLASS C INVESTOR WARRANT For the Purchase of Common Stock (Filed With SEC on April 21, 2006)
- COMMON STOCK PURCHASE AGREEMENT by and between KINGSBRIDGE CAPITAL LIMITED and DISCOVERY LABORATORIES, INC. dated as of April 17, 2006 (Filed With SEC on April 21, 2006)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 21, 2006)
- EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2006)
- ASSIGNMENT OF LEASE AND TEMINATION AND OPTION AGREEMENT (Filed With SEC on March 16, 2006)
- ASSET PURCHASE AGREEMENT among LAUREATE PHARMA, INC. (a Delaware corporation), and DISCOVERY LABORATORIES, INC. (a Delaware corporation) TABLE OF CONTENTS (Filed With SEC on January 3, 2006)
- [Form of] SUBSCRIPTION AGREEMENT (Filed With SEC on December 14, 2005)
- 3,030,304 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENT (Filed With SEC on December 14, 2005)
- STRATEGIC ALLIANCE AGREEMENT by and between DISCOVERY LABORATORIES, INC. (a Delaware corporation) and PHILIP MORRIS USA INC., d/b/a CHRYSALIS TECHNOLOGIES (a Virginia corporation)... (Filed With SEC on December 12, 2005)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on October 27, 2005)
- 4,610,000 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENT (Filed With SEC on February 18, 2005)
- 450,000 Shares DISCOVERY LABORATORIES, INC. Shares of Common Stock ($0.001 par value) PLACEMENT AGENT AGREEMENT (Filed With SEC on February 18, 2005)
- WARRANT AGREEMENT (Filed With SEC on November 9, 2004)
- AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on November 9, 2004)
- AGREEMENT (Filed With SEC on November 9, 2004)
- AMENDED AND RESTATED LOAN AGREEMENT (Filed With SEC on November 9, 2004)
- AMENDED AND RESTATED SECURITY AGREEMENT (Filed With SEC on November 9, 2004)